Dr. Mercola's Censored Library (Private Membership)

Dr. Mercola's Censored Library (Private Membership)

Discussion about this post

User's avatar
Guillermou's avatar
Guillermou
4d

Big Pharma is in cahoots with the agri-food system and government institutions to promote obesity, diabetes, and all sorts of chronic diseases. The indoctrination of children with junk food from childhood is a huge market for Big Pharma, and parents and schools are coached to make children obese. There is one thing most experts agree on: the increased consumption of highly processed foods is a major contributor to the childhood obesity epidemic. The government and the media made a huge fuss about COVID-19, as they worked together to destroy society to keep people "safe" from a "virus." Meanwhile, hundreds of thousands of people die every year from eating processed foods, and no one in a position of power says a word. With 1 in 5 children now obese, Big Pharma is targeting a $50 billion market for weight-loss drugs. Around 16 to 47 percent of the world's adult population has insulin resistance. This condition predisposes individuals to diabetes, neuropathy, nephropathy, dementia, and metabolic syndrome, and compromises quality of life.

The FDA approved 37 drugs and medical products in 2022. Surprisingly, 24 of the new drugs (65 percent) were approved based on a single study. When the 21st Century Cure Act was enacted in December 2016, the federal government facilitated the acceleration of medical product development. The law quickly became a gateway for corruption, allowing the industry to circumvent the once rigorous, evidence-based standards for approving new drugs. By short-circuiting the scientific method, industry and government work hand in hand to flood the market with new drugs that lack adequate safety data.

https://www.theepochtimes.com/health/fda-approved-65-percent-of-new-drugs-in-2022-based-on-a-single-study-5453802 (08/10/2023)

Hundreds of people in the UK have suffered pancreatic problems linked to the use of weight-loss injections such as Ozempic, Wegovy, and Mounjaro. These cases have prompted health authorities to launch an investigation into the side effects of GLP-1 drugs (glucagon-like peptide-1 receptor agonists).

According to the British newspaper The Guardian, the increase in cases of pancreatitis associated with the use of these medications was detected through the Medicines and Healthcare products Regulatory Agency's (MHRA) Yellow Card Scheme.

Pancreatitis is one of the rare adverse reactions listed in the package inserts for these drugs. Theoretically, UK health authorities have detected nearly 400 cases in patients who used Mounjaro, Wegovy, Ozempic, and liraglutide.

Of these, almost half (181) were linked to tirzepatide (Mounjaro), the British newspaper reports. More than a quarter of these cases were reported in 2025. "Along with increased use, we are seeing a rise in the number of Yellow Card reports mentioning GLP-1 drugs and acute pancreatitis," an MHRA spokesperson told The Guardian. The Medicines and Healthcare products Regulatory Agency has announced it will launch a study to investigate the causes of these adverse effects. "This needs to be thoroughly examined." Dr. Alison Cave, director of safety at the MHRA, stated: "Evidence shows that almost a third of drug side effects could be prevented with the introduction of genetic testing. Adverse drug reactions are projected to cost the NHS more than £2.2 billion a year in hospitalizations alone."

https://www.theguardian.com/society/2025/jun/26/weight-loss-diabetes-jab-users-report-pancreas-problems (25/05/26)

Reply
Share
1 reply
mcgdoc's avatar
mcgdoc
4d

https://mcgdoc.substack.com/p/a-severely-vaccine-injured-patient?r=1vfiqs&utm_medium=ios

Reply
Share
1 reply
6 more comments...

No posts

Ready for more?

© 2026 Dr. Joseph Mercola · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture